Patent ID: 11964109
Assignee: GEORGIA TECH RESEARCH CORPORATION
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 8:
9. The method of claim 1, wherein the at least one soluble mediator of cellular activity comprises Interleukin-4 (IL-4), Interleukin-7 (IL-7), Granulocyte-macrophage colony-stimulating factor (GM-CSF), Interleukin-12 p70 (IL-12p70), Interleukin-12 p40 (IL-12p40), Interferon-γ (IFN-γ), LIF, Tumor necrosis factor-α (TNF-α), Macrophage inflammatory protein 1β (MIP-1β), Eotaxin, Interleukin-10 (IL-10), vascular endothelial growth factor (VEGF), Interleukin-2 (IL-2), Interleukin-5 (IL-5), Interleukin-9 (IL-9), Macrophage inflammatory protein 1α (MIP-1α), monokine induced by gamma interferon (MIG), growth-regulated oncogene-α (GRO-α), LIX (CXCL5), granulocyte colony-stimulating factor (G-CSF), Interleukin-1β(IL-1β), Interleukin-3 (IL-3), Interleukin-6 (IL-6), Interleukin-15 (IL-15), Regulated upon Activation, Normal T cell Expressed, and Secreted (RANTES), macrophage colony-stimulating factor (M-CSF), Interleukin-13 (IL-13), monocyte chemoattractant protein 1 (MCP-1), and/or Interleukin-1α (IL-1α).